Literature DB >> 19111107

Where should noninvasive ventilation be delivered?

Nicholas S Hill1.   

Abstract

Noninvasive ventilation (NIV) has assumed an important role in the management of certain types of respiratory failure in acute-care hospitals. However, the optimal location for NIV has been a matter of debate. Some have argued that all patients begun on NIV in the acute-care setting should go to an intensive care unit (ICU), but this is impractical because ICU beds are often unavailable, and it may not be a sensible use of resources. Also, relatively few studies have examined the question of location for NIV. One problem is that various units' capabilities to deliver NIV differ substantially, even in the same hospital. Choosing the appropriate environment for NIV requires consideration of the patient's need for monitoring, the monitoring capabilities of the unit, including both technical and personnel resources (nursing and respiratory therapy), and the staff's skill and experience. In some hospitals NIV is begun most often in the emergency department, but is most often managed in an ICU. Step-down units are often good locations for NIV, but many institutions do not have step-down units. With ICU beds at a premium, many hospitals are forced to manage some NIV patients on general wards, which can be safely done with more stable patients if the ward is suitably monitored and experienced. When deciding where to locate the patient, clinicians must be familiar with the capabilities of the units in their facility and try to match the patient's need for monitoring and the unit's capabilities.

Entities:  

Mesh:

Year:  2009        PMID: 19111107

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  15 in total

1.  Early failure of noninvasive ventilation in COPD: All cornerstones under surveillance?

Authors:  Mohammed AlAhmari; Antonio M Esquinas
Journal:  Intern Emerg Med       Date:  2015-12-28       Impact factor: 3.397

2.  The comparative effectiveness of noninvasive and invasive ventilation in patients with pneumonia.

Authors:  Mihaela S Stefan; Aruna Priya; Penelope S Pekow; Tara Lagu; Jay S Steingrub; Nicholas S Hill; Brian H Nathanson; Peter K Lindenauer
Journal:  J Crit Care       Date:  2017-05-23       Impact factor: 3.425

3.  The authors reply.

Authors:  Mihaela S Stefan; Brian H Nathanson; Peter K Lindenauer
Journal:  Crit Care Med       Date:  2015-11       Impact factor: 7.598

4.  A new horizon for the use of non-invasive ventilation in patients with acute respiratory distress syndrome.

Authors:  Michele Carron
Journal:  Ann Transl Med       Date:  2016-09

5.  The evidence is in: noninvasive ventilation saves lives.

Authors:  Dean R Hess
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

6.  Where is Noninvasive Ventilation Actually Delivered for Acute Respiratory Failure?

Authors:  Aylin Ozsancak Ugurlu; Samy S Sidhom; Ali Khodabandeh; Michael Ieong; Chester Mohr; Denis Y Lin; Irwin Buchwald; Imad Bahhady; John Wengryn; Vinay Maheshwari; Nicholas S Hill
Journal:  Lung       Date:  2015-07-26       Impact factor: 2.584

7.  How Effective are Intensive Care Unit Beds Used in Our Region?

Authors:  Esma Meltem Şimşek; Seval İzdeş; Ümit Murat Parpucu; Fatma Ulus; Mustafa Özgür Cırık; Suheyla Ünver
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-08-15

8.  Effects of Modes, Obesity, and Body Position on Non-invasive Positive Pressure Ventilation Success in the Intensive Care Unit: A Randomized Controlled Study.

Authors:  Murat Türk; Müge Aydoğdu; Gül Gürsel
Journal:  Turk Thorac J       Date:  2018-01-03

9.  Intensive care of the cancer patient: recent achievements and remaining challenges.

Authors:  Elie Azoulay; Marcio Soares; Michael Darmon; Dominique Benoit; Stephen Pastores; Bekele Afessa
Journal:  Ann Intensive Care       Date:  2011-03-23       Impact factor: 6.925

Review 10.  Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies.

Authors:  Ezgi Ozyilmaz; Aylin Ozsancak Ugurlu; Stefano Nava
Journal:  BMC Pulm Med       Date:  2014-02-13       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.